Chronic Non-A, Non-B Hepatitis with Special Reference to the Transfusion-Associated Form

References

• Alter HJ, Holland PV, Morrow AG, Purcell RH, Feinstone SM, Moritsugu Y. Clinical and serological analysis of transfusion-associated hepatitis. Lancet II:838–841,1975
   Web of Science ®Google Scholar
• Prince AM, Grady GF, Hazzi C, Brotman B, Kuhns WJ, Levine RW, Millian SJ. Long-incubation post-transfusion hepatitis without serological evidence of exposure to hepatitis-B virus. Lancet II:241–246,1974
   Google Scholar
• Poynard T, Delfraissy JF, Naveau S, Dubreuil P, Gut JP, Raskine L, Grangeot-Keros L, Pillot J, Chaput JC, Reduction of the observed prevalence of so-called non-A non-B hepatitis using sensitive markers of HBV and herpes viruses infections. Gastroenterol Clin Biol 11:283–287,1987
   PubMedGoogle Scholar
• Pontisso P, Stenico D, Diodati G, Marin G, Caldironi MV, Giacchino R, Realdi G, Alberti A. HBV-DNA sequences are rarely detected in the liver of patients with HBsAg-negative chronic active liver disease and with hepatocellular carcinoma in Italy. Liver 7:206–210,1987
   PubMedGoogle Scholar
• Shafritz D. Presence of hepatitis B virus deoxyribonucleic acid in human tissues under unexpected circumstances. Gastroenterology 89:687–690,1985
   PubMed Web of Science ®Google Scholar
• Thiers V, Kremsdorf D, Schellekens D, Goudeau A, Sninsky J, Nakajima E, Mack D, Driss F, Wands J, Tiollais P, Brechot C. Transmission of hepatitis B from hepatitis-B.seronegative subjects. Lancet II:1273–1276,1988
   Google Scholar
• Thiers V, Fujita Y, Takahashi H, Schellekens H, De Reus A, Driss F, Degott C, Isselbacher K, Tiollais P, Wands J, Bréchot C. Hepatitis B virus DNA sequences in the serum of HBsAg-negative patients with chronic liver disease: Transmission of viral particles to chimpanzees. In Zuckerman AJ ed. Viral hepatitis and liver disease. Alan R. Liss, Inc., New York. 553–557,1988
   Google Scholar
• Feinstone SM, Hoofnagle JH. Non-A, maybe-B hepatitis. N Engl J Med 311:185–189,1984
   PubMed Web of Science ®Google Scholar
• Slusarczyk J, Hess G, Hansson BG, Meyer zum Buschenfelde KH. Lack of hepatitis B virus DNA sequences in sera from patients with acute and chronic liver diseases diagnosed as non-A, non-B hepatitis. Liver 6:337–340,1986
   PubMedGoogle Scholar
• Alter HJ. Transfusion-associated non-A, non-B hepatitis: The first decade. In Zuckerman A J ed. Viral hepatitis and liver disease. Alan R. Liss, Inc., New York. 537–542,1988
   Google Scholar
• Ulich TR, Anders K, Layfield L, Cheng L, Lewin KJ. Chronic active hepatitis of hepatitis B and non-A, non-B etiology. Arch Pathol Lab Med 109:403–407,1985
   PubMed Web of Science ®Google Scholar
• Dienstag JL, Alaama A, Mosley JW, Redeker AG, Purcell RH. Etiology of sporadic hepatitis B surface antigen-negative hepatitis. Ann Intern Med 87:1–6,1977
   PubMed Web of Science ®Google Scholar
• Alter MJ, Gerety RJ, Smallwood LA, Sampliner RE, Tabor E, Deinhardt F, Frösner G, Matanoski GM. Sporadic non-A, non-B hepatitis: Frequency and epidemiology in an urban U.S. population. J Infect Dis 145:886–893,1982
   PubMed Web of Science ®Google Scholar
• Francis DP, Hadler SC, Prendergast TJ, Peterson E, Ginsberg MM, Lookabaugh C, Holmes JR, Maynard JE. Occurrence of hepatitis A, B, non-A/non-B in the United States. CDC sentinel county hepatitis study I. Am J Med 76:69–74,1984
   PubMed Web of Science ®Google Scholar
• Norkrans G, Frösner G, Hermodsson S, Iwarson S. Clinical, epidemiological and prognostic aspects of hepatitis “non-A, non-B” - a comparison with hepatitis A and B. Scand J Infect Dis 11:259–264,1979
   PubMed Web of Science ®Google Scholar
• Weiland O, Berg JVR, Flehmig B, Lindh G, Lundbergh P. Acute viral hepatitis, types A, B and non-A, non-B: A prospective study of the epidemiological, laboratory and prognostic aspects in 280 consecutive cases. Scand J Infect Dis 13:247–255,1981
   PubMed Web of Science ®Google Scholar
• Widell A, Hansson BG, Moestrup T, Serléus Z, Mathiesen LR, Johnsson T. Acute hepatitis A, B and non-A, non-B in a Swedish community over a ten-year period. Scand J Infect Dis 14:253–259,1982
   PubMed Web of Science ®Google Scholar
• Frøland SS, Teien AN, Ulstrup JC. Acute non-A, non-B hepatitis in Norway. Scand J Gastroenterol 17:593–599,1982
   PubMed Web of Science ®Google Scholar
• Müller R, Willers H, Freise J, Höpken W. Wie häufig ist eine chronische Hepatitis als folge der akuten Virushepatitis A und der Hepatitis non-A-non-B? Z Gastroenterol 16:760–767,1978
   PubMedGoogle Scholar
• Busher GL, Skidmore SJ, McKendrick MW, Geddes AM. Sporadic non A non B hepatitis in Birmingham. J Infect 3:45–49,1981
   PubMed Web of Science ®Google Scholar
• Farrow LJ, Stewart JS, Stem H, Clifford RE, Smith HG, Zuckerman AJ. Non-A, non-B hepatitis in West London. Lancet I:982–984,1981
   Google Scholar
• Bamber M, Thomas HC, Bannister B, Sherlock S. Acute type A, B, and non-A, non-B hepatitis in a hospital population in London: Clinical and epidemiological features. Gut 24:561–564,1983
   PubMed Web of Science ®Google Scholar
• Caredda F, D'Arminio Monforte A, Rossi E, Lopez S, Moroni M. Non-A, non-B hepatitis in Milan. Lancet II:48,1981
   Google Scholar
• Bortolotti F, Cadrobbi P, Carretta M, Menghetti F, Ponaro E, Realdi G. Epidemiological aspects on acute viral hepatitis in northern Italy. Scand J Infect Dis 14:161–164,1982
   PubMed Web of Science ®Google Scholar
• Ayoola EA. Viral hepatitis in Africa. In Zuckerman AJ ed. Viral Hepatitis and Liver Disease. Alan R. Liss, Inc., New York. 161–169,1988
   Google Scholar
• Al-Kandari S, Nordenfelt E, Al-Nakib B, Radakrishnan S, Al-Nakib W. Acute non-A, non-B hepatitis in Kuwait. Scand J Infect Dis 19:611–616,1987
   PubMed Web of Science ®Google Scholar
• Datta R, Panda SK, Tandon BN, Madangopalan N, Bose SL, Acharya SK, Nayak NC. Acute sporadic non-A, non-B viral hepatitis of adults in India - epidemiological and immunological studies. J Gastroenterol Hepatol 2:333–345,1987
   Web of Science ®Google Scholar
• Shrestha S. Acute sporadic viral hepatitis in Nepal. Trop Gastroenterol 8:99–105,1987
   PubMedGoogle Scholar
• Chu CM, Sheen IS, Liaw YF. The etiology of acute hepatitis in Taiwan: Acute hepatitis superimposed on HBsAg carrier state as the main etiology of acute hepatitis in areas with high HBsAg carrier rate. Infection 16:233–237,1988
   PubMed Web of Science ®Google Scholar
• Nagata A, Kiyosawa K, koike Y, Miura M, Gibo Y, Sodeyama T, Wada S, Akahane Y, Furuta S. Epidemiology of sporadic non-A, non-B hepatitis in Japan: A comparison with hepatitis A and B. Am J Gastroenterol 80:298–302,1987
   Web of Science ®Google Scholar
• Kiyosawa K, Gibo Y, Sodeyama T, Furuta K, Imai H, Yoda H, Koike Y, Yoshizawa K, Furuta S. Possible infectious causes in 651 patients with acute viral hepatitis during a 10-year period (1976–1985). Liver 7:163–168,1987
   PubMedGoogle Scholar
• Jmelnitzky AC, Basualdo JA, Belloni PO, Ponce de León HH, Garcia C, Curciarello J. Hepatitis no A-no B: Significacion epidemiologica en hepatitis viral aguda y hepatitis cronica activa de consulta hepatologica. Acta Gastroenterol Latinoam 17:15–23,1987
   PubMedGoogle Scholar
• Tateda A, Kikuchi K, Numazaki Y, Shirachi R, Ishida N. Non-B hepatitis in Japanese recipients of blood transfusions: Clinical and serological studies after the introduction of laboratory screening of donor blood for hepatitis B surface antigen. J Infect Dis 139:511–518,1979
   PubMed Web of Science ®Google Scholar
• Alter HJ, Holland PV, Purcell RH, Lander JJ, Feinstone SM, Morrow AG, Schmidt PJ. Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors. Ann Intern Med 77:691–699,1972
   PubMed Web of Science ®Google Scholar
• Tabor E, Hoofnagle JH, Smallwood LA. Studies of donors who transmit posttransfusion hepatitis. Transfusion 19:725–731,1979
   PubMed Web of Science ®Google Scholar
• Tremolada F, Chiappetta F, Noventa F, Valfré C, Ongaro G, Realdi G. Prospective study of posttransfusion hepatitis in cardiac surgery patients receiving only blood or also blood products. Vox Sang 44:25–30,1983
   PubMed Web of Science ®Google Scholar
• Feinstone SM, Kapikian AZ, Purcell RH, Alter HJ, Holland PV. Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med 292:767–770,1975
   PubMed Web of Science ®Google Scholar
• Aach RD, Szmuness W, Mosley JW, Hollinger FB, Kahn RA, Stevens CE, Edwards VM, Werch J. Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients. The transfusion-transmitted viruses study. N Engl J Med 304:989–994,1981
   PubMed Web of Science ®Google Scholar
• Alter HJ, Purcell RH, Holland PV, Alling DW, Koziol DE. Donor transaminase and recipient hepatitis. Impact on blood transfusion services. JAMA 246:630–634,1981
   PubMed Web of Science ®Google Scholar
• Stevens CE, Aach RD, Hollinger FB, Mosley JW, Szmuness W, Kahn R, Werch J, Edwards V. Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of the transfusion-transmitted viruses study. Ann Intern Med 101:733–738,1984
   PubMed Web of Science ®Google Scholar
• Koziol DE, Holland PV, Alling DW, Melpolder JC, Solomon RE, Purcell RH, Hudson LM, Shoup FJ, Krakauer H, Alter HJ. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med 104:488–495,1986
   PubMed Web of Science ®Google Scholar
• Grillner L, Bergdahl S, Jyrälä A. Non-A, non-B hepatitis after open-heart surgery in Sweden. Scand J Infect Dis 14:171–175,1982
   PubMed Web of Science ®Google Scholar
• Olsson R, Hermodsson S, Roberts D, Waldenström J. Hepatic dysfunction after open-heart surgery. Scand J Thor Cardiovasc Surg 18:217–22,1984
   PubMed Web of Science ®Google Scholar
• Widell A, Sundström G, Hansson BG, Fex G, Moestrup T, Nordenfelt E. Relation between donor transaminase and recipient hepatitis non-A, non-B in Sweden. Vox Sang 54:154–159,1988
   PubMed Web of Science ®Google Scholar
• Lagerstedt A, Leikola J, Merikallio E, Ukkonen P. Post-transfusion non-A, non-B hepatitis in Finland: A prospective study. Scand J Clin Lab Invest 42:567–570,1982
   PubMed Web of Science ®Google Scholar
• Katchaki J N, Siem TH, Brouwer R, Loon AM, van der Logt JThM. Post-transfusion non-A, non-B hepatitis in the Netherlands. Brit Med J 282:107–108,1981
   PubMed Web of Science ®Google Scholar
• Reesink HW, Leentvaar-Kyupers A, van der Poel CL, Lelie PN, Pietersz RNI, Mulder-Folkerts DKF, Pieters T, van den Ende A, Schaasberg W, Coutinho RA. Non-A, non-B posttransfusion hepatitis in open heart surgery in the Netherlands. In Zuckerman AJ Viral Hepatitis and Liver disease. Alan R. Liss, Inc., New York 558–560,1988
   Google Scholar
• Glück D, Gaus W, Wieland C, Kubanek B. Transfusions-hepatitis. Häufigkeit und Risikovergleich zwischen Bluttransfusion und Operation. Deutsche Med Wochenschrift 113:1463–1468,1988
   PubMedGoogle Scholar
• Collins JD, Bassendine MF, Codd AA, Collins A, Ferner RE, James OFW. Prospective study of posttransfusion hepatitis after cardiac surgery in a British centre. Brit Med J 287:1422–1424,1983
   PubMedGoogle Scholar
• Hemandéz JM, Piqueras J, Carrera A, Triginer J. Posttransfusion hepatitis in Spain. A prospective study. Vox Sang 44:231–237,1983
   PubMed Web of Science ®Google Scholar
• Hoyos M, Sarrión JB, Pérez-Castellanos T, Marty ML, Bernguer J. Markers for non-A, non-B hepatitis. Ann Intern Med 105:467,1986
   PubMed Web of Science ®Google Scholar
• Sanchez-Quijano A, Lissen E, Diaz-Torres MA, Rivera F, Pineda JA, Leal M, Garcia de Pesquera F, Castro R, Munoz J. Prevention of post-transfusion non-A, non-B hepatitis by non-specific immunoglobulin in heart surgery patients. Lancet I:1245–1249,1988
   Google Scholar
• Aymard JP, Janot C, Gayet S, Guillemin C, Canton P, Gaucher P, Streiff F. Post-transfusion non-A, non-B hepatitis after cardiac surgery. Vox Sang 51:236–238,1986
   PubMed Web of Science ®Google Scholar
• Tremolada F, Realdi G, Noventa F, Alberti A, Ponada E, Valfré C, Gallucci V. Post-transfusion hepatitis in Italy. Lancet I:853–854,1982
   Google Scholar
• Colombo M, Oldani S, Donato MF, Borzio M, Santese R, Roffi L, Viganó, Cargnel A. A multicenter, prospective study of posttransfusion hepatitis in Milan. Hepatology 7:709–712,1987
   PubMed Web of Science ®Google Scholar
• Ito S, Tsuji Y, Iwasaki A, Kitagawa N, Tamura Y, Fujii S. Relationship between guanase activity in donor blood and the incidence of posttransfusional non-A, non-B hepatitis, and a possible method for preventing posttransfusional hepatitis. Hepatology 6:990–993,1986
   PubMed Web of Science ®Google Scholar
• Ohori H, Nagatsuka Y, Kanno A, Abe Y, Ishida N. Two distinct types of non-A, non-B hepatitis in a cardiovascular surgical unit. J Med Virol 11:105–113,1983
   PubMed Web of Science ®Google Scholar
• Cossart YE, Kirsch S, Ismay SL. Post-transfusion hepatitis in Australia. Lancet I:208–213,1982
   Google Scholar
• Tremolada F, Loreggian M, Antona C, Cirillo F, Noventa F, Realdi G. Blood-transmitted and clotting-factor-transmitted non-A, non-B hepatitis. J Clin Gastroenterol 10:413–418,1988
   PubMed Web of Science ®Google Scholar
• Aledort LM, Levine PH, Hilgartner M, Blatt P, Spero JA, Goldberg JD, Bianchi L, Desmet V, Scheuer P, Popper H, Berk PD. A study of liver biopsies and liver disease among hemophiliacs. Blood 66:367–372,1985
   PubMed Web of Science ®Google Scholar
• Dienstag JL, Alter HJ. Non-A, non-B hepatitis: Evolving epidemiological and clinical perspective. Semin Liver Dis 6:67–81,1986
   PubMed Web of Science ®Google Scholar
• Hellings JA, van der Veen-du Prie J, Boender P. Transmission of non-A, non-B hepatitis by leucocyte preparations. In Zuckerman AJ ed. Viral Hepatitis and Liver Disease. Alan R Liss, Inc., New York 543–549,1988
   Google Scholar
• Björkander J, Cunningham-Rundles C, Lundin P, Olsson R, Söderström R, Hanson LÅ. Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency. Am J Med 84:107–111,1988
   PubMed Web of Science ®Google Scholar
• Lever AM, Brown D, Webster ADB, Thomas HC. Non-A, non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulin. Lancet II:1062–1064,1984
   Google Scholar
• Williams PE, Yap PL, Gillon J, Crawford RJ, Galea G, Cuthbertson B. Non-A, non-B hepatitis transmission by intravenous immunoglobulin. Lancet II:501,1988
   Google Scholar
• Weiland O, Mattsson L, Glaumann H. Non-A, non-B hepatitis after intravenous gammaglobulin. Lancet I:976–977,1986
   Google Scholar
• Stradtmann H, Wiese M. Die Bedeutung der Virushepatitis im Dialyzezentrum für Patienten und Pflegekräfteeine 5-Jahres-Übersicht. Z Gesamte Inn Med 42:612–614,1987
   PubMedGoogle Scholar
• Guyer B, Bradley DW, Bryan JA, Maynard JE. Non-A, non-B hepatitis among participants in a plasmapheresis stimulation program. J Infect Dis 139:634–640,1979
   PubMed Web of Science ®Google Scholar
• Muss N, Frösner GG, Sandhofer F. Epidemic outbreak of non-A, non-B hepatitis in a plasmapheresis center. I: Epidemiological observations. Infection 13:57–60,1985
   PubMed Web of Science ®Google Scholar
• Laskus T, Cianciara J, Slusarczyk J. Follow-up of NANB hepatitis outbreak in plasmapheresis unit. Lancet I:391,1989
   Google Scholar
• Tong MJ, Thursby M, Rakela J. Studies on maternal-infant transmission of the viruses which cause acute hepatitis. Gastroenterology 80:999–1004,1981
   PubMed Web of Science ®Google Scholar
• Tabor E. Non-A, non-B hepatitis in children: A review of the literature. Hepatology Rapid Lit Rev 18:LXXXIX,1988
   Google Scholar
• Wiese M, Pöhlandt K. Zur postpartalen Transmission des NANB-Hepatitisvirus (NANBHV) - epidemiologische und klinische Daten. Zeitschrift Klin Med 42:1605–1608,1987
   Google Scholar
• Bortolotti F, Bertaggia A, Cadrobbi P, Crivellaro C, Ponaro E, Realdi G. Epidemiological aspects of acute viral hepatitis in drug abusers. Infection 10:277–279,1982
   PubMed Web of Science ®Google Scholar
• Norkrans G, Frösner G, Hermodsson S, Iwarson S. Multiple hepatitis attacks in drug addicts. JAMA 243:1056–1058,1980
   PubMed Web of Science ®Google Scholar
• Weiland O, Berg JVR, Bjorvatn B, Flehmig B, Lundbergh P. Acute viral hepatitis A, B and non-A, non-B in Stockholm in the 1950s and in the 1970s: A comparison. Infection 9:268–274,1981
   PubMed Web of Science ®Google Scholar
• Khuroo MS. Study of an epidemic of non-A, non-B hepatitis: Possibility of another human hepatitis virus distinct from posttransfusion non-A, non-B type. Amer J Med 68:818–824,1980
   PubMed Web of Science ®Google Scholar
• Wong DC, Purcell RH, Sreenivasan MA. Epidemic and endemic hepatitis in India: Evidence for non-A/non-B hepatitis virus etiology. Lancet II:876–878,1980
   Google Scholar
• Bradley DW, Krawczynski K, Cook EH, McCaustland KA, Robertson BH, Humphrey CD, Kane MA, Spelbring J, Weisfuse I, Andjaparidze A, Balayan M, Stetler H, Velazquez O. Enterically transmitted non-A, non-B hepatitis: Etiology of disease and laboratory studies in nonhuman primates. In Zuckerman AJ ed. Viral Hepatitis and Liver Disease. Alan R. Liss, Inc., New York. 138–147,1988
   Google Scholar
• Tabor E, Seeff LB, Gerety RJ. Chronic non-A, non-B hepatitis carrier state. Transmissible agent documented in one patient over a six-year period. Lancet II:140–143,1980
   Google Scholar
• Ahtone J, Francis D, Bradley D, Maynard J. Non-A, non-B hepatitis in a nurse after percutaneous needle exposure. Lancet I:1142,1980
   Google Scholar
• Alter HJ, Holland PV, Purcell RH, Popper H. Transmissible agents in non-A, non-B hepatitis. Lancet I:459–462,1978
   Google Scholar
• Tabor E, Drucker JA, Hoofnagle JH, April M, Gerety RJ, Seeff LB, Jackson DR, Barker LF, Pineda-Tamondong G. Transmission of non-A, non-B hepatitis from man to chimpanzee. Lancet I:463–466,1978
   Google Scholar
• Hollinger FB, Gitnick GL, Aach RD, Szmuness W, Mosley JW, Stevens CE, Peters RL, Weiner JM, Werch JB, Lander JJ. Non-A, non-B hepatitis transmission in chimpanzees: A project of the transfusion-transmitted viruses study group. Intervirology 10:60–68,1978
   PubMed Web of Science ®Google Scholar
• Shimizu YK, Feinstone SM, Purcell RH, Alter HJ, London WT. Non-A, non-B hepatitis: Ultrastructural evidence for two agents in experimentally infected chimpanzees. Science 205:197–200,1979
   PubMed Web of Science ®Google Scholar
• Jackson D, Tabor E, Gerety RJ. Acute non-A, non-B hepatitis: Specific ultrastructural alterations in endoplasmic reticulum of infected hepatocytes. Lancet I:1249–1250,1979
   Google Scholar
• Bradley DW, Maynard JE, Cook EH. Non-A/non-B hepatitis in experimentally infected chimpanzees: Cross-challenge and electron microscopic studies. J Med Virol 6:185–201,1980
   PubMed Web of Science ®Google Scholar
• Tabor E, Gerety RJ. The chimpanzee animal model for non-A, non-B hepatitis: New applications. In: Szmuness W, Alter HJ, Maynard JE, eds. Viral hepatitis. Philadelphia: Franklin Institute Press 305 317,1982
   Google Scholar
• Hoofnagle JH, Gerety, RJ, Tabor E, Feinstone SM, Barker LF, Purcell RH. Transmission of non-A, non-B hepatitis. Ann Intern Med 87:14–20,1977
   PubMed Web of Science ®Google Scholar
• Bradley DW, Mc Caustland KA, Cook EH, Ebert JW, Maynard JE. Non-A, non-B hepatitis in chimpanzees: Effects of immunosuppression on course of disease and recovery of tubule-forming agent from infected liver. In: Vyas GN, Dienstag JL, Hoofnagle JH, eds. Viral hepatitis and liver disease. Orlando: Grune & Stratton Inc. 451–458,1984
   Google Scholar
• Bradley DW, Maynard JE. Etiology and natural history of posttransfusion and enterically-transmitted non-A, non-B hepatitis. Semin Liver Dis 6:56–66,1986
   PubMed Web of Science ®Google Scholar
• Bradley DW, Maynard JE, Popper H, Cook EH, Ebert JW, McCaustland KA, Schable CA, Fields H A. Posttransfusion non-A, non-B hepatitis: Physiochemical properties of two distinct agents. J Infect Dis 148:254–265,1983
   PubMed Web of Science ®Google Scholar
• He LF, Alling D, Popkin T, Shapiro M, Alter HJ, Purcell RH. Determining the size of non-A, non-B hepatitis virus by filtration. J Infect Dis 156:636–640,1987
   PubMed Web of Science ®Google Scholar
• Bradley DW, McCaustland KA, Cook EH, Schable CA, Ebert JW, Maynard JE. Posttransfusion non-A, non-B hepatitis in chimpanzees. Physiochemical evidence that the tubuleforming agent is a small, enveloped virus. Gastroenterology 88:773–779,1985
   PubMedGoogle Scholar
• Tsiquaye KN, Portmann B, Tovey G. Non-A, non-B hepatitis in persistent carriers of hepatitis B virus. J Med Virol 11:79–89,1983
   Web of Science ®Google Scholar
• Bradley DW, Krawczynski K, Humphrey CD, McCaustland KA. Biochemically silent posttransfusion non-A, non-B hepatitis interferes with superinfection by hepatitis A virus. Intervirology 27:86–90,1987
   PubMed Web of Science ®Google Scholar
• Bradley DW, Maynard JE, McCaustland KA. Non-A, non-B hepatitis in chimpanzees: Interference with acute hepatitis A virus and chronic hepatitis B virus infections. J Med Virol 11:207–213,1983
   PubMed Web of Science ®Google Scholar
• Brotman B, Prince AM, Huima T. Interference between non-A, non-B and hepatitis B virus infections in chimpanzees. J Med Virol 11:191–205,1983
   PubMed Web of Science ®Google Scholar
• Liaw Y-F, Chu C-M, Chang-Chien C-S, Wu C-S. Simultaneous acute infections with hepatitis non-A, non-B and B viruses. Digest Dis Sci 27:762–764,1982
   PubMed Web of Science ®Google Scholar
• Seto B, Coleman WG, Iwarson S, Gerety RJ. Detection of reverse transcriptase activity in association with the non-A, non-B hepatitis agent(s). Lancet II:941–944,1984
   Google Scholar
• Iwarson S, Schaff Z, Seto B, Norkrans G, Gerety RJ. Retrovirus-like particles in hepatocytes of patients with transfusion-acquired non-A, non-B hepatitis. J Med Virol 16:37–45,1985
   PubMed Web of Science ®Google Scholar
• Casoli C, Tremolada F, Lori F, Scovassi I, Bertazzoni U, Starcich R, Alberti A. Reverse transcriptase activity in post-transfusion non-A, non-B hepatitis: Characterization and association with retrovirus-like particles in serum. Serodiagnosis Immunotherapy 1:339–346,1987
   Google Scholar
• Tremolada F, Casoli C, Loreggian M, Albertini R, Realdi G, Alberti A. Reverse transcriptase activity in post-transfusion hepatitis: Relation to liver disease activity and long-term outcome. Serodiagnosis Immunotherapy 1:347–352,1987
   Google Scholar
• Prince AM, Williams BAA, Huima T. Isolation of a virus from chimpanzee liver cell cultures inoculated with sera containing the agent of non-A, non-B hepatitis. Lancet II:1071–1075,1984
   Google Scholar
• Hallam NF. Non-A, non-B hepatitis: Reverse transcriptase activity? Lancet II:665,1985
   Google Scholar
• Sibrowski W, von Wulffen H, Henning H, Laufs R. Low prevalence of particle-associated reverse transcriptase activity in serum from patients with non-A, non-B hepatitis. Z Gastroenterol 25:673–676,1987
   PubMed Web of Science ®Google Scholar
• Brahm J, McClure MO, Sommerfelt MA, Exley MA, Weiss RA, Fagan EA, Williams R. Lack of reverse transcriptase activity in serum in sporadic post-transfusional and presumed epidemic or water-borne forms of severe non-A, non-B hepatitis. J Med Virol 25:157–164,1988
   PubMed Web of Science ®Google Scholar
• Williams B, Prince AM, Huima T, Brotman B. Spumaviruses isolated from sources containing agents of non-A, non-B (NANB) hepatitis do not cause NANB hepatitis. J Med Virol 24:263–274,1988
   PubMed Web of Science ®Google Scholar
• Mosley JW, Redeker AG, Feinstone SM, Purcell RH. Multiple hepatitis viruses in multiple attacks of acute viral hepatitis. N Engl J Med 296:75–78,1977
   PubMed Web of Science ®Google Scholar
• Pastore G, Monno L, Santantonio T, Trotta F, Schiraldi O. Monophasic and polyphasic pattern of alanine aminotransferase in acute non-A, non-B hepatitis. Clinical and prognostic implications. Hepato-Gastroenterol 32:155–158,1985
   PubMedGoogle Scholar
• Barcena R, Suarez-Garcia E, Gil LA, Moreira VF, Garcia-Hoz F, Milicua JM, Boixeda de Miquel D, Ruiz del Arbol L, Pascasio JM, Garcia-Plaza A. Posttransfusion non-A, non-B hepatitis. A prospective study. Liver 5:71–76,1985
   PubMedGoogle Scholar
• Aach RD, Lander JJ, Sherman LA, Miller WV, Kahn RA, Gitnick GL, Hollinger FB, Werch J, Szmuness W, Stevens CE, Kellner A, Weiner JM, Mosley JW. Transfusion-transmitted viruses: Interim analysis of hepatitis among transfused and nontransfused patients. In Vyas GN, Cohen SN, Schmidt R. Viral hepatitis. Philadelphia: Franklin Institute Press 383–396,1978
   Google Scholar
• Hollinger FB, Mosley JW, Szmuness W. Transfusion-transmitted viruses study: Experimental evidence for two non-A, non-B hepatitis agents. J Infect Dis 142:400–407,1980
   PubMed Web of Science ®Google Scholar
• Yoshizawa H, Itoh Y, Iwakiri S. Demonstration of two different types of non-A, non-B hepatitis by reinjection and cross-challenge studies in chimpanzees. Gastroenterology 81:107–113,1981
   PubMed Web of Science ®Google Scholar
• Eder G, Bianchi L, Gudat F. Transmission of non-A, non-B hepatitis to chimpanzees: A second and third episode caused by the same inoculum. In Zuckerman AJ, eds. Viral Hepatitis and Liver Disease. Alan R. Liss, Inc., New York 550–552,1988
   Google Scholar
• Brotman B, Prince AM, Huima T. Non-A, non-B hepatitis: Is there more than a single blood-borne strain? J Infect Dis 151:618–625,1985
   PubMed Web of Science ®Google Scholar
• Candidate cause identified of non-A, non-B virus. Nature 333:195,1988
   Web of Science ®Google Scholar
• Balayan MS, Andjaparidze AG, Savinskaya SS. Evidence for a virus in non-A/non-B hepatitis transmitted via the fecal-oral route. Intervirology 20:23–31,1983
   PubMed Web of Science ®Google Scholar
• Arankalle VA, Sreenivasan MA, Popper H, Ticehurst J, Kapikian AZ, Pavri KM, Purcell RH. Etiological association of a virus-like particle with enterically transmitted non-A, non-B hepatitis. Lancet I:550–553,1988
   Google Scholar
• Purcell RH, Ticehurst JR. Enterically transmitted non-A, non-B hepatitis: Epidemiology and clinical characteristics. In Zuckerman AJ ed. Viral Hepatitis and Liver Disease. Alan R. Liss, Inc., New York. 131-137,1988
   Google Scholar
• Dienstag JL. Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterology 85:439–462,1983
   PubMed Web of Science ®Google Scholar
• Bamber M, Murray A, Arborgh BAM, Scheuer PJ, Kernoff PBA, Thomas HC, Sherlock S. Short incubation non-A, non-B hepatitis transmitted by factor VIII concentrates in patients with congenital coagulation disorders. Gut 22:854–859,1981
   PubMed Web of Science ®Google Scholar
• Meyers JD, Dienstag JL, Purcell RH, Thomas ED, Holmes KK. Parenterally transmitted non-A, non-B hepatitis. An epidemic reassessed. Ann Intern Med 87:57–59,1977
   PubMed Web of Science ®Google Scholar
• Gimson AES, White YS, Eddleston Alwf, Williams R. Clinical and prognostic differences in fulminant hepatitis type A, B and non-A, non-B. Gut 24:1194–1198,1983
   PubMed Web of Science ®Google Scholar
• Gimson AE, O'Grady J, Ede RJ, Portmann B, Williams R. Late onset hepatic failure: Clinical, serological and histological features. Hepatology 6:288–294,1986
   PubMed Web of Science ®Google Scholar
• Bal V, Amin SN, Rath S, Kamat SA, Zuckerman AJ, Marathe SN, Kamat RS. Virological markers and antibody responses in fulminant viral hepatitis. J Med Virol 23:75–82,1987
   PubMed Web of Science ®Google Scholar
• Marguiles A, Bernuau J, Balayan MS, Andjaparidze AG, Dubois F, Goudeau A, Rueff B, Benhamou JP. Non-A, non-B fulminant viral hepatitis in France in returnees from Asia and Africa. Dig Dis Sciences 32:1151–1154,1987
   PubMed Web of Science ®Google Scholar
• Rakela J, Lange SM, Ludwig J, Baldus WP. Fulminant hepatitis: Mayo Clinic experience with 34 cases. Mayo Clin Proc 60:289–292,1985
   PubMed Web of Science ®Google Scholar
• Vickers CR, Hubscher SG, Skidmore SJ, McMaster P, Elias E. Sporadic non-A, non-B hepatitis as a cause of acute liver failure. In Zuckerman AJ ed. Viral Hepatitis and Liver Disease. Alan R. Liss, Inc., New York 561–563,1988
   Google Scholar
• Zeldis JB, Dienstag JL, Gale RP. Aplastic anemia and non-A, non-B hepatitis. Am J Med 74:64–68,1983
   PubMed Web of Science ®Google Scholar
• Pikis A, Kavakiotis J, Manios S. Incidence of aplastic anemia in viral hepatitis in children. Scand J Infect Dis 20:109–110,1988
   PubMed Web of Science ®Google Scholar
• Bannister P, Miloszewski K, Barnard D, Losowsky MS. Fatal marrow aplasia associated with non-A, non-B hepatitis. Brit Med J 286:1314–1315,1983
   PubMedGoogle Scholar
• Diez JSJ, Llames RV, Escudero JCM, Hernandéz JMG, Pintado HB, Cavero JIT, Ortega EO. Aplasia de medula osea como complicacion de la hepatitis non-A non-B: Comunicacion de un nuevo caso de evolucion fatal. Gastroenterol Y Hepatol 10:509–512,1987
   Google Scholar
• Van de Stouwe RA, Attia, AA, Karanas A, Ciavarella D, Grieco MH. Transient agranulocytosis associated with non-A, non-B hepatitis. Gastroenterology 85:186–189,1983
   PubMed Web of Science ®Google Scholar
• Dhingra K, Michels SD, Winton EF, Gordon DS. Transient bone marrow aplasia associated with non-A, non-B hepatitis. Am J Hematol 29:168–171,1988
   PubMed Web of Science ®Google Scholar
• Shrestha SM, Misra K, Shrestha S, Shrestha KB. An epidemic of HNANB(E) in Nepal. Hepatology Rapid Lit Rev 18:LIV-LVI,1988
   Google Scholar
• Epidemiological notes and reports. Enterically transmitted non-A, non-B hepatitis - Mexico. Morb Mort Weekly Rep 36:597–602,1987
   PubMedGoogle Scholar
• Arankalle VA, Chadha MS, Mehendale SM, Banerjee K. Outbreak of enterically transmitted non-A, non-B hepatitis among schoolchildren. Lancet II:1199–1200,1988
   Google Scholar
• Alter HJ, Purcell RH, Feinstone SM, Holland PV, Morrow AG. Non-A, non-B hepatitis: A review and interim report of an ongoing prospective study. In Vyas GN, Cohen SN, Schmidt R. Viral hepatitis. Philadelphia: Franklin Institute Press 359–369,1978
   Google Scholar
• Koretz RL, Stone O, Mousa M, Gitnick GL. Non-A, non-B posttransfusion hepatitis - a decade later. Gastroenterology 88:1251–1254,1985
   PubMed Web of Science ®Google Scholar
• Widell A, Sundström G, Hansson BG, Fex G, Moestrup T, Nordenfelt E. Post-transfusion hepatitis type non-A, non-B in southern Sweden: Occurrence and significance. Scand J Infect Dis 19:603–610,1987
   PubMed Web of Science ®Google Scholar
• Feinman SV, Berris B, Bojarski S. Posttransfusion hepatitis in Toronto, Canada. Gastroenterology 95:464–469,1988
   PubMed Web of Science ®Google Scholar
• Rakela J, Redeker AG. Chronic liver disease after acute non-A, non-B viral hepatitis. Gastroenterology 77:1200–1202,1979
   PubMed Web of Science ®Google Scholar
• Sampliner RE, Woronow DI, Alter MJ, Smallwood LA, Tabor E, Deinhardt F, Roggendorf M, Gerety RJ. Community-acquired non-A, non-B hepatitis: Clinical characteristics and chronicity. J Med Virol 13:125–130,1984
   PubMed Web of Science ®Google Scholar
• Tassopoulos NC, Alikiotis M, Nicolakakis P, Limotirakis F. Acute sporadic hepatitis in Greece. Hepatology Rapid Lit Rev 18:128–129,1988
   Google Scholar
• Realdi G, Tremolada F, Bortolotti F, Alberti A, Rigoli AM, Noventa CA, Busachi CA, Rugge M. The natural history of post-transfusion and sporadic non-A, non-B hepatitis in Italy. In Viral hepatitis and delta infection, 55–66, Alan R. Liss, Inc, New, York, 1983
   Google Scholar
• Khuroo MS, Saleem M, Teli MR, Sofi MA. Failure to detect chronic liver disease after epidemic non-A, non-B hepatitis. Lancet II:97–98,1980
   Google Scholar
• Iwarson S, Lindberg J, Lundin P. Progression of hepatitis non-A, non-B to chronic active hepatitis. J Clin Pathol 32:351–355,1979
   PubMed Web of Science ®Google Scholar
• Jové J, Sanchez-Tapias JM, Bruguera M, Mas A, Costa J, Barrera JM, Rodés J. Post-transfusional vs. sporadic non-A, non-B chronic hepatitis. A clinico-pathological and evolutive study. Liver 8:42–47,1988
   PubMedGoogle Scholar
• Mathieson R, Sampliner RE, Latham PS, Rogers EL, Alter MJ. Chronic liver disease following community-acquired non-A, non-B hepatitis. Am J Clin Pathol 85:353–356,1986
   PubMed Web of Science ®Google Scholar
• Wejstál R, Lindberg J, Lundin P, Hansson BG, Norkrans G. Chronic non-A, non-B hepatitis in drug addicts - a follow-up study. Infection 16:163–166,1988
   PubMed Web of Science ®Google Scholar
• Bamber M, Murray AK, Weller IVD, Scheuer PJ, Thomas HC, Sherlock S. Clinical and histological features of a group of patients with sporadic non-A, non-B hepatitis. J Clin Pathol 34:1175–1180,1981
   PubMed Web of Science ®Google Scholar
• Wejstál R, Lindberg J, Lundin P, Norkrans G. Chronic non-A, non-B hepatitis. A long-term follow-up study in 49 patients. Scand J Gastroenterol 22:1115–1122,1987
   PubMed Web of Science ®Google Scholar
• Ochs HD, Fischer SH, Virant FS, Lee ML, Mankarious S, Kingdon HS, Wedgwodd RJ. Non-A, non-B hepatitis after intravenous gammaglobulin. Lancet I:322–323,1986
   Google Scholar
• Webster ADB, Lever AML. Non-A, non-B hepatitis after intravenous gammaglobulin. Lancet I:322,1986
   Google Scholar
• Hay CRM, Triger DR, Preston FE, Underwood JCE. Progressive liver disease in haemophilla: An understated problem? Lancet I:1495–1498,1985
   Google Scholar
• Schimpf K. Liver disease in haemophilla. Lancet I:323,1986
   Google Scholar
• Lashner BA, Jonas RB, Tang HS, Evans AA, Ozeran SE, Baker AL. Chronic hepatitis: Disease factors at diagnosis predictive of mortality. Am J Med 85:609–614,1988
   PubMed Web of Science ®Google Scholar
• Uchiumi K, Omata M, Okuda K. A follow-up study on the prognosis of chronic hepatitis- difference between type B and non-B. Acta Hepatol Jap 28:1015–1021,1987
   Google Scholar
• Kiyosawa K, Akahane Y, Nagata A, Furuta S. Hepatocellular carcinoma after non-A, non-B posttransfusion hepatitis. Am J Gastroenterol 79:777–781,1984
   PubMed Web of Science ®Google Scholar
• Tabor E. Hepatocellular carcinoma: Possible etiologies in patients without serological evidence of hepatitis B virus infection. J Med Virol 27:1–6,1989
   PubMed Web of Science ®Google Scholar
• Kunin CM. Serum hepatitis from whole blood: Incidence and relation to source of blood. Am J Med Sci 237:293–303,1959
   PubMed Web of Science ®Google Scholar
• Walsh JH, Purcell RH, Morrow AG, Chanock RM, Schmidt PJ. Posttransfusion hepatitis after open-heart operations. JAMA 211:261–265,1970
   PubMed Web of Science ®Google Scholar
• Seeff LB, Wright EC, Zimmerman HJ, Hoofnagle JH, Dietz AA, Felsher BF, Garcia-Pont PH, Gerety RJ, Greenlee HB, Kiernan T. Leevy CM, Nath N, Schiff ER, Schwartz C, Tabor E, Tamburro C, Vlahcevic Z, Zemel R, Zimmon DS. Posttransfusion hepatitis. 1973–1975: A Veterans Administration cooperative study. In Vyas GN, Cohen SN, Schmidt R. Viral hepatitis. Philadelphia: Franklin Institute Press 371–381,1978
   Google Scholar
• Cowart VS. Nationwide ALT testing to prevent non-A, non-B hepatitis still on hold. JAMA 246:2791–2792,1981
   PubMedGoogle Scholar
• Barker LF. Non-A, non-B hepatitis: ALT and anti-HBc testing. Vox Sang 55:127,1988
   Web of Science ®Google Scholar
• Habibi B. Surrogate testing for non-A, non-B hepatitis in France. Vox Sang 55:127,1988
   Web of Science ®Google Scholar
• Ito S, Tsuji Y, Kitagawa N, Akihika I, Syundo J, Tamura Y, Kishi S, Mori H. Clinical value of the guanase screening test in donor blood for prevention of posttransfusional non-A, non-B hepatitis. Hepatology 8:383–384,1988
   PubMed Web of Science ®Google Scholar
• Council of scientific affairs. Autologous blood transfusions. JAMA 256:2378–2380,1986
   PubMed Web of Science ®Google Scholar
• Ladd DJ, Hillis A. A new method for evaluating the hepatitis risk of the multiply-implicated donor. Transfusion 24:80–82,1984
   PubMed Web of Science ®Google Scholar
• Haugen RK, Hill GE. A large-scale autologous blood program in a community hospital. A contribution to the community's blood supply. JAMA 257:1211–1214,1987
   PubMed Web of Science ®Google Scholar
• Silvergleid AJ. Safety and effectiveness of predeposit autologous transfusions in preteen and adolescent children. JAMA 257:3403–3404,1987
   PubMed Web of Science ®Google Scholar
• Lennon RL, Hosking MP, Gray JR, Klassen RA, Popovsky MA, Warner MA. The effects of intraoperative blood salvage and induced hypotension on transfusion requirements during spinal surgical procedures. Mayo Clin Proc 62:1090–1094,1987
   PubMed Web of Science ®Google Scholar
• Weniger J, Shanahan R. Reduction of bank blood requirements in cardiac surgery. Thorac Cardiovasc Surgeon 30:142–146,1981
   Web of Science ®Google Scholar
• Mc Carthy PM, Popovsky MA, Schaff HV, Orszulak TA, Williamson KR, Taswell HF, Ilstrup DM. Effect of blood conservation efforts in cardiac operations at the Mayo clinic. Mayo Clin Proc 63:225–229,1988
   PubMed Web of Science ®Google Scholar
• Cosgrove DM, Thurer RL, Lytle BW, Gill CG, Peter M, Loop FD. Blood conservation during myocardial revascularization. Ann Thorac Surg 28:184–189,1979
   PubMed Web of Science ®Google Scholar
• Preston FE, Hay CRM, Dewar MS, Greaves M, Triger DR. Non-A, non-B hepatitis and heat-treated factor VIII concentrates. Lancet II:213,1985
   Google Scholar
• Purcell RH, Gerin JL, Popper H, London WT, Cicmanec J, Eichberg JW, Newman J, Hrinda ME. Hepatitis B virus, hepatitis non-A, non-B virus and hepatitis delta virus in lyophilized antihemophilic factor: Relative sensitivity to heat. Hepatology 5:1091–1099,1985
   PubMed Web of Science ®Google Scholar
• Schimpf K, Mannucci PM, Kreutz W, Brackmann HH, Auerswald G, Ciavarella N, Mösseler J, DeRosa V, Kraus B, Brueckmann C, Mancuso G, Mittler U, Haschke F, Morfini M. Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions. N Engl J Med 316:918–922,1987
   PubMed Web of Science ®Google Scholar
• Colombo M, Carnelli V, Gazengel C, Mannucci PM, Savidge GF, Schimpf K, the European study group. Transmission of non-A, non-B hepatitis by heat-treated factor VIII concentrate. Lancet II:1–4,1985
   Google Scholar
• Mannuci PM, Zanetti AR, Colombo M, the study group of the fondazione dell'Emofilia. Prospective study of hepatitis after factor VIII concentrate exposed to hot vapour. Brit J Haematol 68:427–430,1988
   PubMed Web of Science ®Google Scholar
• Einarsson M, Prince AM, Brotman B. Removal of non-A, non-B hepatitis virus from a concentrate of the coagulation factors II, VII, IX and X by hydrophobic interaction chromatography. Scand J Infect Dis 17:141–146,1985
   PubMed Web of Science ®Google Scholar
• Prince AM, Horowitz B, Brotman B. Sterilization of hepatitis and HTLV-III viruses by exposure to tri(n-butyl)phosphate and sodium cholate. Lancet I:706–710,1986
   Google Scholar
• Alter HJ, Morel PA, Dorman BP, Smith GC, Creagan RP, Wiesehahn GP, Corash L, Popper H, Eichberg JW. Photochemical decontamination of blood components containing hepatitis B and non-A, non-B virus. Lancet II:1446–1450,1988
   Google Scholar
• Stephan W, Dichtelüller H, Prince AM, Brotman B, Huima T. Inactivation of the Hutchinson strain of hepatitis non-A, non-B virus in intravenous immunoglobulin by beta-propiolactone. J Med Virol 26:227–232,1988
   PubMed Web of Science ®Google Scholar
• Prince AM, Stephan W, Dichtelmüller H, Brotman B, Huima T. Inactivation of the Hutchinson strain of non-A, non-B hepatitis virus by combined use of beta-propiolactone and ultraviolet irradiation. J Med Virol 16:119–125,1985
   PubMed Web of Science ®Google Scholar
• Prince AM, Stephan W, Brotman B. Beta-propiolactone/ultraviolet irradiation: A review of its effectiveness for inactivation of viruses in blood derivates. Rev Infect Dis 5:92–107,1983
   PubMedGoogle Scholar
• Knodell RG, Ginsberg AL, Conrad ME, Bell CJ. Efficacy of prophylactic gamma-globulin in preventing non-A, non-B post-transfusion hepatitis. Lancet I:557–561,1976
   Google Scholar
• Knodell RG, Conrad ME, Ishak KG. Development of chronic liver disease after acute non-A, non-B post-transfusion hepatitis. Gastroenterology 72:902–909,1977
   PubMed Web of Science ®Google Scholar
• Gibo Y, Kiyosawa K, Furuta K, Nakamura M, Uemura K, Furuta S. Non-A, non-B acute hepatitis after needle-stick accident. Acta Hepatol Jap 29:7–15,1988
   Google Scholar
• Schiff ER. Hepatitis prophylaxis policies. JAMA 254:2969,1985
   Web of Science ®Google Scholar
• Seeff LB, Hoofnagle JH. Immunoprophylaxis of viral hepatitis. Gastroenterology 77:161–182,1979
   PubMed Web of Science ®Google Scholar
• Conrad ME. Prevention of post-transfusion hepatitis. Lancet II:217,1988
   Google Scholar
• Hoofnagle JH, Mullen KD, Jones DB, Rustgi V, di Bisceglie A, Peters M, Waggoner JG, Park Y, Jones EA. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. N Engl J Med 315:1575–1578,1986
   PubMed Web of Science ®Google Scholar
• Hoofnagle JH, Di Bisceglie AM. Therapy of chronic viral hepatitis: Chronic hepatitis D and non-A, non-B hepatitis. In Zuckerman AJ ed. Viral hepatitis and liver disease. Alan R. Liss, Inc., New York. 823-830,1988
   Google Scholar
• Thomson B, Lever AML, Doran M, Webster ADB. Alpha-interferon therapy for non-A, non-B hepatitis transmitted by gammaglobulin replacement therapy. Lancet I:539–541,1987
   Google Scholar
• Schvarcz R, Weiland O, Glaumann H. Alpha interferon treatment of chronic non-A, non-B hepatitis caused by intravenous gammaglobulin. Scand J Infect Dis 20:231–232,1988
   PubMed Web of Science ®Google Scholar
• Jacyna MR, Brooks MG, Loke RHT, Murray-Lyon IM, Thomas HC. Randomized controlled trial of interferon alpha (lymphoblastoid interferon) in chronic non-A, non-B hepatitis. Br Med J 298:80–82,1989
   PubMed Web of Science ®Google Scholar
• Weiland O, Schvarcz R, Wejstál R, Norkrans G, Foberg U, Frydén A. Interferon alpha-2b treatment of chronic posttransfusion non-A, non-B hepatitis: Interim results of a randomized controlled open study. Scand J Infect Dis 21:in press,1989
   Google Scholar
• Smedsrød B. Aminoterminal propeptide of type III procollagen is cleared from the circulation by receptor-mediated endocytosis in liver endothelial cells. Collagen Rel Res 8:375–388, 1988
   PubMedGoogle Scholar
• Hahn EG. Blood analysis of liver fibrosis. J Hepatology 1:67–73,1984
   Web of Science ®Google Scholar
• Bentsen KD, Horn T, Risteli J, Risteli L, Engström-Laurent A, Hørslev-Petersen K, Lorenzen I, the Copenhagen study group on fibrotic diseases. Serum aminoterminal type III procollagen peptide and the 7S domain of type IV collagen in patients with alcohol abuse. Liver 7:339–346,1987
   PubMedGoogle Scholar
• Colombo M, Annoni G, Donato MF, Conte D, Martines D, Zaramella MG, Bianchi PA, Pipemo A, Tiribelli C. Serum type III procollagen peptide in alcoholic liver disease and idiopathic hemochromatosis: Its relationship to hepatic fibrosis, activity of the disease and iron overload. Hepatology 5:475–479,1985
   PubMed Web of Science ®Google Scholar
• Torres-Salinas M, Parés A, Caballeria J, Jiménez W, Herdia D, Bruguera M, Rodés J. Serum procollagen type III peptide as a marker of hepatic fibrogenesis in alcoholic hepatitis. Gastroenterology 90:1241–1246,1986
   PubMed Web of Science ®Google Scholar
• Annoni G, Cargnel A, Colombo M, Hahn EG. Persistent elevation of the aminoterminal peptide of procollagen type III in serum of patients with acute viral hepatitis distinguishes chronic active hepatitis from resolving or chronic persistent hepatitis. J Hepatology 2:379–388,1986
   PubMed Web of Science ®Google Scholar
• Bentsen KD, Hørslev-Petersen K, Junker P, Juhl E, Lorenzen I, the Copenhagen Hepatitis acuta programme. Serum aminoterminal procollagen type III peptide in acute viral hepatitis. Liver 7:96–105,1987
   PubMedGoogle Scholar
• McCullough AJ, Stassen WN, Wiesner RH, Czaja AJ. Serial determinations of the aminoterminal peptide of type III procollagen in severe chronic active hepatitis. J Lab Clin Med 109:55–61,1987
   PubMed Web of Science ®Google Scholar
• McCullough AJ, Stassen WN, Wiesner RH, Czaja AJ. Serum type III procollagen peptide concentrations in severe chronic active hepatitis: Relationship to cirrhosis and disease activity. Hepatology 7:49–54, 1987
   PubMed Web of Science ®Google Scholar
• Surrenti C, Casini A, Milani S, Ambu S, Ceccatelli P, D'Agata A. Is determination of serum N-terminal procollagen type III peptide (sPIIIP) a marker of hepatic fibrosis? Dig Dis Sci 32:705–709, 1987
   PubMed Web of Science ®Google Scholar
• Frei A, Zimmermann A, Weigand K. The N-terminal propeptide of collagen type III in serum reflects activity and degree of fibrosis in patients with chronic liver disease. Hepatology 4:830–834, 1984
   PubMed Web of Science ®Google Scholar
• Weigand K, Zaugg PY, Frei A, Zimmermann A. Long-term follow-up of serum N-terminal propeptide of collagen type III levels in patients with chronic liver disease. Hepatology 4:835–838, 1984
   PubMed Web of Science ®Google Scholar
• Babbs C, Hunt LP, Haboubi NY, Smith A, Rowan BP, Warnes TW. Type III procollagen peptide: A marker of disease activity and prognosis in primary biliary cirrhosis. Lancet I:1021–1024, 1988
   Google Scholar
• Bjermer L, Engström-Laurent A, Lundgren R, Rosenhall L, Hällgren R. Hyaluronate and type III procollagen peptide concentrations in bronchoalveolar lavage fluid as markers of disease activity in farmer's lung. Brit Med J 295:803–806, 1987
   PubMed Web of Science ®Google Scholar
• Arrago JP, Poirier O, Chomienne C, D'Agay MF, Najean Y. Type III aminoterminal propeptide of procollagen in some haematological malignancies. Scand J Haematol 36:288–294, 1986
   PubMedGoogle Scholar
• Hørslev-Petersen K, Bentsen KD, Junker P, Lorenzen I. Serum amino-terminal type III procollagen peptide in rheumatoid arthritis. Arthritis Rheum 29:592, 1986
   PubMed Web of Science ®Google Scholar
• Tiribelli C. Serum type III procollagen peptide in alcoholic liver disease and idiopathic hemochromatosis: Its relationship to hepatic fibrosis, activity of the disease and iron overload. Hepatology 5:475–479, 1985
   PubMed Web of Science ®Google Scholar
• Fraser JRE, Laurent TC, Engström-Laurent A, Laurent UGB. Elimination of hyaluronic acid from the blood stream in the human. Clin Exp Pharm Phys 11:17–25, 1984
   PubMed Web of Science ®Google Scholar
• Smedsrød B, Pertoft H, Eriksson S, Fraser JRE, Laurent TC. Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells. Biochem J 223:617–626, 1984
   PubMed Web of Science ®Google Scholar
• Nyberg A, Engström-Laurent A, Lööd L. Serum hyaluronate in primary biliary cirrhosis - a biochemical marker for progressive liver damage. Hepatology 8:142–146, 1988
   PubMed Web of Science ®Google Scholar
• Engström-Laurent A, Lööf L, Nyberg A, Schröder T. Increased serum levels of hyaluronate in liver disease. Hepatology 5:638–642, 1985
   PubMed Web of Science ®Google Scholar
• Frébourg T, Delpech B, Bercoff E, Senant J, Bertrand P, Deugnier Y, Bourreille J. Serum hyaluronate in liver diseases: Study by enzymoimmunological assay. Hepatology 6:392–395, 1986
   PubMed Web of Science ®Google Scholar
• Lindqvist U, Weiland O, Lööf L, Mattsson L, Samuelsson K. Sequential measurements of hyaluronan and procollagen type III peptide in acute viral hepatitis. A six months follow up study. Submitted.
   Google Scholar
• Engström-Laurent A, Hällgren R. Circulating hyaluronate in rheumatoid arthritis: Relationship to inflammatory activity and the effect of corticosteroid therapy. Ann Rheum Dis 44:83–88, 1985
   PubMed Web of Science ®Google Scholar
• Dahl IMS, Laurent TC. Concentration of hyaluronan in serum of untreated cancer patients with special reference to patients with mesothelioma. Cancer 62:326–330, 1988
   PubMed Web of Science ®Google Scholar
• Frébourg T, Lerebours G, Delpech B, Benhamou D, Bertrand P, Maingonnat C, Boutin C, Nouvet G, Serum hyaluronate in malignant pleural mesothelioma. Cancer 59:2104–2107, 1987
   PubMed Web of Science ®Google Scholar
• Berg S, Brodin B, Hesselvik F, Laurent TC, Maller R. Elevated plasma hyaluronan in septicemia. Scand J Clin Lab Invest 48:727–732, 1988
   PubMed Web of Science ®Google Scholar
• Menghini G. One second needle biopsy of the liver. Gastroenterology 25:190–199, 1958
   Google Scholar
• Broström C, Weiland O. Ett engangsset för leverbiopsi lätthanterligt och med fä komplikationer. Läkartidningen 78:976–977, 1981 (in Swedish)
   Google Scholar
• Bianchi L, De Groote J, Desmet VJ, Gedigk P, Korb G, Popper H, Poulsen H, Scheuer PJ, Schmid M, Thaler H, Wepler W. Acute and chronic hepatitis revisited. Lancet II:914–919, 1977
   Google Scholar
• Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kieman TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431–435, 1981
   PubMed Web of Science ®Google Scholar
• Lindh G, Weiland O, Glaumann H. The application of a numerical scoring system for evaluating the histological outcome in patients with chronic hepatitis B followed in long term. Hepatology 8:98–103, 1988
   PubMed Web of Science ®Google Scholar
• Rohde H, Vargas L, Hahn E, Kalbfleisch H, Bruguera M, Timpl R. Radioimmunoassay for type III procollagen peptide and its application to human liver disease. Eur J Clin Invest 9:451–459, 1979
   PubMed Web of Science ®Google Scholar
• Engström-Laurent A, Laurent UBG, Lilja K, Laurent TC. Concentration of sodium hyaluronate in serum. Scand J Clin Lab Invest 45:497–504, 1985
   PubMed Web of Science ®Google Scholar
• Brandt R, Hedlöf E, Åsman I, Bucht A, Tengblad A. A convenient radiometric assay for hyaluronan. Acta Otolaryngol 442( Suppl.):31–35, 1987
   Google Scholar
• Tengblad A. Quantitative analysis of hyaluronate in nanogram amounts. Biochem J 185:101–105, 1980
   PubMed Web of Science ®Google Scholar
• Tengblad A. Affinity chromatography on immobilized hyaluronate and its application to the isolation of hyaluronate binding proteins from cartilage. Biochim Biophys Acta 578:281–289, 1979
   PubMed Web of Science ®Google Scholar
• Siegel S, Castellan Jr N. Nonparametric statistics for the behavioral sciences. McGraw-Hill Book Company 1988
   Google Scholar
• Realdi G, Alberti A, Rugge M, Rigoli AM, Tremolada F, Schivazappa L, Ruol A. Long-term follow-up of acute and chronic non-A, non-B post-transfusion hepatitis: Evidence of progression to liver cirrhosis. Gut 23:270–275, 1982
   PubMed Web of Science ®Google Scholar
• Berman M, Alter HJ, Ishak KG, Purcell RH, Jones EA. The chronic sequelae of non-A, non-B hepatitis. Ann Intern Med 91:1–6, 1979
   PubMed Web of Science ®Google Scholar
• Theodossi A, Skene AM, Portmann RP, Knill-Jones RS, Patrick RS, Tate RA, Kealey W, Jarvis KJ, O'Brian DJ, Williams R. Observer variation in assessment of liver biopsies including analysis by kappa statistics. Gastroenterology 79:232–241,1980
   PubMed Web of Science ®Google Scholar
• Soloway RD, Baggenstoss AH, Schoenfield LJ, Summerskill WHJ. Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy. Am J Dig Dis 16:1082–1086,1971
   PubMedGoogle Scholar
• De Groote J, Desmet VJ, Gedigk P, Korb G, Popper H, Poulsen H, Scheuer PJ, Schmid M, Thaler H, Uehlinger E, Wepler W. A classification of chronic hepatitis. Lancet 2:626–628,1968
   PubMed Web of Science ®Google Scholar
• Baptista A, Bianchi L, De Groote J, Desmet VJ, Ishak KG, Korb G, MacSween RNM, Popper H, Poulsen H, Scheuer PJ, Schmid M, Thaler H. The diagnostic significance of periportal hepatic necrosis and inflammation. Histopathol 12:569–579,1988
   PubMed Web of Science ®Google Scholar
• Bianchi L. Necroinflammatory liver diseases. Semin Liver Dis 6:185–198,1986
   PubMed Web of Science ®Google Scholar
• MacSween RNM. Morphological changes within the liver. Hepatology Rapid Lit Rev 17:3520–3522,1987
   Google Scholar
• Popper H. General pathology of the liver: Light microscopic aspects serving diagnosis and interpretation. Semin Liver Dis 6:175–184,1986
   PubMed Web of Science ®Google Scholar
• Hoofnagle JH, Alter HJ. Chronic non-A, non-B hepatitis. In Barker LF, Dodd RY, eds. Infection, immunity and blood transfusion. New York: Alan R. Liss, Inc. 63–69,1985
   Google Scholar
• Anonymous. Morphology of non-A, non-B hepatitis. Fata morgana or facts of tomorrow? Hepatology Rapid Lit Rev 14:XI-XV,1984
   Google Scholar
• Cooksley WGE, Braöbear RA, Robinson W, Harrison M, Halliday JW, Powell LW, Ng H-S, Seah C-S, Okuda K, Scheuer PJ, Sherlock S. The prognosis of chronic active hepatitis without cirrhosis in relation to bridging necrosis. Hepatology 6:345–348,1986
   PubMed Web of Science ®Google Scholar
• Combes B. The initial morphologic lesion in chronic hepatitis, important or unimportant? Hepatology 6:518–522,1986
   PubMed Web of Science ®Google Scholar
• Vanstapel MJ, van Steenbergen W, De Wolf-Peeters C, Desmyter J, Fevery J, De Groote J, Desmet VJ. Prognostic significance of piecemeal necrosis in acute viral hepatitis. Liver 3:46–57,1983
   PubMedGoogle Scholar
• Popper H. Changing concepts of the evolution of chronic hepatitis and the role of piecemeal necrosis. Hepatology 3:758–762,1983
   PubMed Web of Science ®Google Scholar
• Koretz RL, Stone O, Gitnick GL. The long-term course of non-A, non-B post-transfusion hepatitis. Gastroenterology 79:893–898,1980
   PubMed Web of Science ®Google Scholar
• Vucelic B, Hadzic N, Dubravcic D. Chronic persistent hepatitis. Long-term prospective study on the natural course of the disease. Scand J Gastroenterol 23:551–554,1988
   PubMed Web of Science ®Google Scholar
• Kryger P, Aldershvile J, Christoffersen P, Hardt F, Juhl E, Mathiesen LR, Nielsen JO, Poulsen H, the Copenhagen hepatitis acuta programme (CHAP). Acute non-A, non-B hepatitis - clinical, epidemiological and histological characteristics. Scand J Infect Dis 12:165–169,1980
   PubMed Web of Science ®Google Scholar
• Muss N, Frösner GG, Sandhofer F. Epidemic outbreak of non-A, non-B hepatitis in a plasmapheresis center. II: Clinical observations and a four-year follow-up of patients. Infection 13:61–65,1985
   PubMed Web of Science ®Google Scholar
• Weissberg JI, Andres LL, Smith CI, Weick S, Nichols JE, Garcia G, Robinson WS, Merigan TC, Gregory PB. Survival in chronic hepatitis B. An analysis of 379 patients. Ann Intern Med 101:613–616,1984
   PubMed Web of Science ®Google Scholar
• Liaw Y-F, Tai D-I, Chu C-M, Chen T-J. The development of cirrhosis in patients with chronic type B hepatitis: A prospective study. Hepatology 8:493–496, 1988
   PubMed Web of Science ®Google Scholar
• Aach RD, Kahn RA. Post-transfusion hepatitis: Current perspectives. Ann Intern Med 92:539–546,1980
   PubMed Web of Science ®Google Scholar
• Seeff LB, Zimmerman HJ, Wright EC, Finkelstein JD, Garcia-Pont P, Greenlee HB, Dietz AA, Leevy CM, Tamburro CH, Schiff ER, Schimmel EM, Zemel R, Zimmon DS, McCollum RW. A randomized, double blind controlled trial of the efficacy of immune serum globulin for the prevention of post-transfusion hepatitis. Gastroenterology 72:111–121,1977
   PubMed Web of Science ®Google Scholar
• Senior JR. Reflections upon the incidence of posttransfusion hepatitis in various parts of the world. Amer J Gastroenterol 49:298–303,1968
   PubMed Web of Science ®Google Scholar
• Högman C. Fran blodgivarcentral till avdelning för transfusionsmedicin. Nordisk Medicin 102:74–76,1987 (in Swedish)
   PubMedGoogle Scholar
• Högman C. Riskerna bör inte överskattas. Lükartidningen 84:1237–1238,1987 (in Swedish)
   Google Scholar
• Socialstyrelsens föreskrifter om blodgivning, blodtransfusion mm. Socialstyrelsens författningssamling 27, 1984 (in Swedish)
   Google Scholar
• Socialstyrelsens föreskrifter och allmänna rad angáende AIDS. Socialstyrelsens författningssamling 4,1985 (in Swedish)
   Google Scholar
• Bentsen KD, Lanng C, Hørslev-Petersen K, Risteli J. The aminoterminal propeptide of type III procollagen and basement membrane components in serum during wound healing in man. Acta Chir Scand 154:97–101,1988
   PubMedGoogle Scholar